• Letter or Testimony
  • March 21, 2014

340B Regulations - Issues to Consider

The Association, with America’s Essential Hospitals and Safety Net Hospitals for Pharmaceutical Access (SNHPA), submitted a joint letter to Mary Wakefield, administrator of the Health Resources and Services Administration (HRSA).

The letter was in anticipation of a comprehensive regulation from HRSA intended to address a variety of issues regarding the 340B Drug Discount Program. Issues highlighted in the letter include manufacturer integrity provisions, patient definition and duplicate discount. The Association asks HRSA to consider these issues as they draft the proposed regulation.

Association Contact: Liz Parry, (202) 753-5392